Jianyuan Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jianyuan Zhang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Harry C. Dorn
Virginia Tech Carilion Research Institute, Roanoke, Virginia, and Department of Chemistry , Virginia Polytechnic Institute and State University , Blacksburg , Virginia , USA
1 shared publication- Harry C. Dorn
Department of Chemistry
1 shared publication - Jerry I. Hirsch
Department of Radiology, Virginia Commonwealth University, 1101 East Marshall Street, Richmond, VA 23298, USA
1 shared publication - Jianqiao Luo
Department of Radiology, Virginia Commonwealth University, 1101 East Marshall Street, Richmond, VA 23298, USA
1 shared publication - John D. Wilson
Department of Radiology, Virginia Commonwealth University, 1101 East Marshall Street, Richmond, VA 23298, USA
1 shared publication - Michael D. Shultz
Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, 1101 East Marshall Street, Richmond, VA 23298, USA
1 shared publication
Latest Publications
- 1 January 2014
- Published by Taylor & Francis in Fullerenes, Nanotubes and Carbon Nanostructures
- Vol. 22 (1-3) , 35-46
NMR Studies of the Dynamic Motion of Encapsulated Ions and Clusters in Fullerene Cages: A Wheel Within a Wheel
- 1 January 2014
- Published by Taylor & Francis in Fullerenes, Nanotubes and Carbon Nanostructures
- Vol. 22 (1-3) , 35-46
NMR Studies of the Dynamic Motion of Encapsulated Ions and Clusters in Fullerene Cages: A Wheel Within a Wheel
- Open Access
- 10 May 2012
- Published by MDPI AG in Applied Sciences
- Vol. 2 (2) , 465-478
A Dual PET/MR Imaging Nanoprobe: 124I Labeled Gd3N@C80
The current report describes the development of a dual modality tomographic agent for both positron emission tomography and magnetic resonance imaging (PET/MRI). The dual-modality agent in this study was based on a 124I (PET) radiolabeled tri-gadolinium endohedral metallofullerene Gd3N@C80 (MRI) nanoprobe platform. The outer surface of the fullerene cage of the Gd3N@C80 metallofullerenes was surface functionalized with carboxyl and hydroxyl groups (f-Gd3N@C80) using previously developed procedures and subsequently iodinated with 124I to produce 124I-f-Gd3N@C80 nanoprobe. Orthotopic tumor-bearing rats were infused intratumorally by convection-enhanced delivery (CED) with the 124I-f-Gd3N@C80 agent and imaged by MRI or micro PET. The anatomical positioning and distribution of the 124I-f-Gd3N@C80 agent were comparable between the MRI and PET scans. The 124I-f-Gd3N@C80 dual-agent distribution and infusion site within the tumor was clearly evident in both T1- and T2-weighted MR images. The results demonstrate the successful preparation of a dual-modality imaging agent, 124I-f-Gd3N@C80, which could ultimately be used for simultaneous PET/MR imaging.
- 10 May 2012
- Published by MDPI AG in Applied Sciences
- Vol. 2 (2) , 465-478
Open AccessA Dual PET/MR Imaging Nanoprobe: 124I Labeled Gd3N@C80
The current report describes the development of a dual modality tomographic agent for both positron emission tomography and magnetic resonance imaging (PET/MRI). The dual-modality agent in this study was based on a 124I (PET) radiolabeled tri-gadolinium endohedral metallofullerene Gd3N@C80 (MRI) nanoprobe platform. The outer surface of the fullerene cage of the Gd3N@C80 metallofullerenes was surface functionalized with carboxyl and hydroxyl groups (f-Gd3N@C80) using previously developed procedures and subsequently iodinated with 124I to produce 124I-f-Gd3N@C80 nanoprobe. Orthotopic tumor-bearing rats were infused intratumorally by convection-enhanced delivery (CED) with the 124I-f-Gd3N@C80 agent and imaged by MRI or micro PET. The anatomical positioning and distribution of the 124I-f-Gd3N@C80 agent were comparable between the MRI and PET scans. The 124I-f-Gd3N@C80 dual-agent distribution and infusion site within the tumor was clearly evident in both T1- and T2-weighted MR images. The results demonstrate the successful preparation of a dual-modality imaging agent, 124I-f-Gd3N@C80, which could ultimately be used for simultaneous PET/MR imaging.